Davood Khalili

Davood Khalili

Auto-generated profile, based on publicly available information

Davood Khalili

Prevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in The Lancet
Verified
Journal Article
Open access
LALeandra Abarca-Gómez
Leandra Abarca-Gómez
ZAZiad A Abdeen
Ziad A Abdeen
ZHZargar Abdul Hamid
Zargar Abdul Hamid
NANiveen M Abu-Rmeileh
Niveen M Abu-Rmeileh
BABenjamin Acosta-Cazares
Benjamin Acosta-Cazares
MEMajid Ezzati
Majid Ezzati
Underweight, overweight, and obesity in childhood and adolescence are associated with adverse health consequences throughout the life-course. Our aim was to estimate worldwide trends in mean body-mass index (BMI) and a comprehensive set of BMI categories that cover underweight to obesity in children and adolescents, and to compare trends with those of adults. We pooled 2416 population-based studies with measurements of height and weight on 128·9 million participants aged 5 years and older, including 31·5 million aged 5-19 years. We used a Bayesian hierarchical model to estimate trends from 1975 to 2016 in 200 countries for mean BMI and for prevalence of BMI in the following categories for children and adolescents aged 5-19 years: more than 2 SD below the median of the WHO growth reference for children and adolescents (referred to as moderate and severe underweight hereafter), 2 SD to more than 1 SD below the median (mild underweight), 1 SD below the median to 1 SD above the median (healthy weight), more than 1 SD to 2 SD above the median (overweight but not obese), and more than 2 SD above the median (obesity). Regional change in age-standardised mean BMI in girls from 1975 to 2016 ranged from virtually no change (-0·01 kg/m2 per decade; 95% credible interval -0·42 to 0·39, posterior probability [PP] of the observed decrease being a true decrease=0·5098) in eastern Europe to an increase of 1·00 kg/m2 per decade (0·69-1·35, PP>0·9999) in central Latin America and an increase of 0·95 kg/m2 per decade (0·64-1·25, PP>0·9999) in Polynesia and Micronesia. The range for boys was from a non-significant increase of 0·09 kg/m2 per decade (-0·33 to 0·49, PP=0·6926) in eastern Europe to an increase of 0·77 kg/m2 per decade (0·50-1·06, PP>0·9999) in Polynesia and Micronesia. Trends in mean BMI have recently flattened in northwestern Europe and the high-income English-speaking and Asia-Pacific regions for both sexes, southwestern Europe for boys, and central and Andean Latin America for girls. By contrast, the rise in BMI has accelerated in east and south Asia for both sexes, and southeast Asia for boys. Global age-standardised prevalence of obesity increased from 0·7% (0·4-1·2) in 1975 to 5·6% (4·8-6·5) in 2016 in girls, and from 0·9% (0·5-1·3) in 1975 to 7·8% (6·7-9·1) in 2016 in boys; the prevalence of moderate and severe underweight decreased from 9·2% (6·0-12·9) in 1975 to 8·4% (6·8-10·1) in 2016 in girls and from 14·8% (10·4-19·5) in 1975 to 12·4% (10·3-14·5) in 2016 in boys. Prevalence of moderate and severe underweight was highest in India, at 22·7% (16·7-29·6) among girls and 30·7% (23·5-38·0) among boys. Prevalence of obesity was more than 30% in girls in Nauru, the Cook Islands, and Palau; and boys in the Cook Islands, Nauru, Palau, Niue, and American Samoa in 2016. Prevalence of obesity was about 20% or more in several countries in Polynesia and Micronesia, the Middle East and north Africa, the Caribbean, and the USA. In 2016, 75 (44-117) million girls and 117 (70-178) million boys worldwide were moderately or severely underweight. In the same year, 50 (24-89) million girls and 74 (39-125) million boys worldwide were obese. The rising trends in children's and adolescents' BMI have plateaued in many high-income countries, albeit at high levels, but have accelerated in parts of Asia, with trends no longer correlated with those of adults. Wellcome Trust, AstraZeneca Young Health Programme.

1 May 2015 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
KHKaveh Hajifathalian
Kaveh Hajifathalian
PUPeter Ueda
Peter Ueda
YLYuan Lu
Yuan Lu
MWMark Woodward
Mark Woodward
AAAlireza Ahmadvand
Alireza Ahmadvand
GDGoodarz Danaei
Goodarz Danaei

2 May 2016 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AHAnna Helgadottir
Anna Helgadottir
SGSolveig Gretarsdottir
Solveig Gretarsdottir
GTGudmar Thorleifsson
Gudmar Thorleifsson
EHEirikur Hjartarson
Eirikur Hjartarson
ASAsgeir Sigurdsson
Asgeir Sigurdsson
KSKari Stefansson
Kari Stefansson

1 November 2019 in The Lancet Diabetes & Endocrinology
Verified
Journal Article
Closed access
FAFereidoun Azizi
Fereidoun Azizi
FHFarzad Hadaegh
Farzad Hadaegh
FHFarhad Hosseinpanah
Farhad Hosseinpanah
PMParvin Mirmiran
Parvin Mirmiran
AAAtieh Amouzegar
Atieh Amouzegar
DKDavood Khalili
Davood Khalili

1 March 2016 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
FBFarideh Bagherzadeh-Khiabani
Farideh Bagherzadeh-Khiabani
ARAzra Ramezankhani
Azra Ramezankhani
FAFereidoun Azizi
Fereidoun Azizi
FHFarzad Hadaegh
Farzad Hadaegh
ESEwout W. Steyerberg
Ewout W. Steyerberg
DKDavood Khalili
Davood Khalili

27 September 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTMaryam Tohidi
Maryam Tohidi
MHMitra Hasheminia
Mitra Hasheminia
RMReza Mohebi
Reza Mohebi
DKDavood Khalili
Davood Khalili
FHFarhad Hosseinpanah
Farhad Hosseinpanah
FHFarzad Hadaegh
Farzad Hadaegh
To examine, the predictors of incident chronic kidney disease (CKD) in a community-based cohort of Middle East population, during a mean follow-up of 9.9 years. In a sample of 3313 non-CKD Iranian adults ≥20 years the estimated glomerular filtration rate (eGFR) was calculated at baseline and at three year intervals during three consecutive phases. The eGFR <60 mL/min/1.73 m2 was defined as CKD. Multivariate Logistic regression analysis was used to determine the independent variables associated with incident CKD. The incidence density rates of CKD were 285.3 and 132.6 per 10,000 person-year, among women and men, respectively. Female gender per se was associated with higher risk of CKD, compared with males. Among women, age, eGFR, known diabetes, being single or divorced/widowed, hypertension (marginally significant) and current smoking were independent risk factors for CKD; however the intermediate degree of education and family history of diabetes decreased the risk by 40% (P<0.05). Among male subjects, independent predictors of developing CKD included aging and hypertension (with significantly higher risk than in women, P for interaction2% of individuals develops CKD each year. Our findings confirmed that sex- specific risk predictors should be considered in primary prevention for incident CKD.